Displaying 1 to 17 of 17 investments
Country Date Notes
BioRelix Inc
Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.
United States Seed
Initial investment. Active
BioRelix Inc
Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.
United States 4 Jun 2007 Series A
Follow-on investment. Round participant. Active
BrainCells Inc
A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases.
United States 1 Apr 2008 Series B
Active
Cambrios Technologies Corp
Developer of proprietary nanostructured electronic materials for the display industry
United States 1 Nov 2009 Series D
Initial investment. Round participant. Active
Cerulean Pharma Inc
United States 1 Jan 2008 Series B
Concert Pharmaceuticals Inc
A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.
United States N/A
Active
Genocea Biosciences Inc
United States N/A
MacroGenics Inc
Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases.
United States N/A
Active
Magen BioSciences Inc
United States N/A
MAP Pharmaceuticals Inc
Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. 
United States N/A
Metabolon Inc
Provider of biomarker discovery and analysis
United States 7 Dec 2009 Series C
MiddleBrook Pharmaceuticals Inc
A pharmaceutical company engages in the development and commercialization of anti-infective drug products.
United States N/A
Nanosys Inc
Nanotechnology-enabled systems
United States N/A
Active
Sirtris Pharmaceuticals Inc
United States 19 Apr 2006 Series C
Active
Theraclone Sciences Inc
United States 1 Mar 2010 N/A
Theraclone Sciences Inc
United States 1 Sep 2011 Series B
VLST Corp
United States N/A